Literature DB >> 32363788

Functionalization of Ti substrate with pH-responsive naringin-ZnO nanoparticles for the reconstruction of large bony after osteosarcoma resection.

Yulu Yang1, Bailong Tao1, Yi Gong2, Rui Chen3, Weihu Yang1, Chuanchuan Lin1, Maowen Chen1, Lu Qin1, Yile Jia1, Kaiyong Cai1,4.   

Abstract

After bone tumor resection, the large bony deficits are commonly reconstructed with Ti-based metallic endoprosthesis, which provide immediate stable fixation and allow early ambulation and weight bearing. However, when used in osteosarcoma resection, Ti implant-relative infection and tumor recurrence were recognized as the two critical factors for implantation failure. Hence, in this work, a novel zinc oxide nanoparticle decorating with naringin was prepared and immobilized onto Ti substrate. The drugs delivery profiles proved that in the bacterial infection and Warburg effect of osteosarcoma-induced acidic condition, naringin and Zn2+ can be released easily from the functional Ti substrate. The anti-osteosarcoma and antibacterial assay showed the delivered naringin and Zn2+ can induce a remarkable increase of oxidative stress in bacteria (Escherichia coli and Staphylococcus aureus) and osteosarcoma (Saos-2 cells) by producing reactive oxygen species (ROS). Accumulation of ROS results in damage of bacterial biofilm and bacterial membrane, leading to the leakage of bacterial RNA and DNA. Meanwhile, the increase of ROS induces osteosarcoma cell apoptosis by activating ROS/extracellular signal-regulated kinase signaling pathway. Furthermore, in vitro cellular experiments, including cell viability, alkaline phosphatase activity, collagen secretion, extracellular matrix mineralization level, indicated that the functional Ti substrate exhibited great potential for osteoblasts proliferation and differentiation. Hence, this study provides a simple and promising strategy of developing multifunctional Ti-based implants for the reconstruction of large bony after osteosarcoma resection.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Naringin; ZnO nanoparticles; anti-osteosarcoma; antibacterial; titanium

Year:  2020        PMID: 32363788     DOI: 10.1002/jbm.a.36977

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K/Akt/mTOR signaling pathway.

Authors:  Xingtao Ge; Gang Zhou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 2.  Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma.

Authors:  Mahmood Barani; Mahwash Mukhtar; Abbas Rahdar; Saman Sargazi; Sadanand Pandey; Misook Kang
Journal:  Biosensors (Basel)       Date:  2021-02-20

3.  A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies.

Authors:  Maryam Ghanbari-Movahed; Gloria Jackson; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

Review 4.  Current Knowledge on the Oxidative-Stress-Mediated Antimicrobial Properties of Metal-Based Nanoparticles.

Authors:  Nour Mammari; Emmanuel Lamouroux; Ariane Boudier; Raphaël E Duval
Journal:  Microorganisms       Date:  2022-02-14

Review 5.  Traditional Chinese Medicine Compound-Loaded Materials in Bone Regeneration.

Authors:  Guiwen Shi; Chaohua Yang; Qing Wang; Song Wang; Gaoju Wang; Rongguang Ao; Dejian Li
Journal:  Front Bioeng Biotechnol       Date:  2022-02-18

Review 6.  Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.

Authors:  Jin Zhang; Yandai Lin; Zhe Lin; Qi Wei; Jiaqi Qian; Renjie Ruan; Xiancai Jiang; Linxi Hou; Jibin Song; Jianxun Ding; Huanghao Yang
Journal:  Adv Sci (Weinh)       Date:  2021-12-19       Impact factor: 16.806

7.  Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules.

Authors:  Noor Akbar; Zara Aslam; Ruqaiyyah Siddiqui; Muhammad Raza Shah; Naveed Ahmed Khan
Journal:  AMB Express       Date:  2021-07-10       Impact factor: 3.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.